Assessment of seizure susceptibility in pilocarpine epileptic and nonepileptic Wistar rats and of seizure reinduction with pentylenetetrazole and electroshock models

Epilepsia

Volumn 50, Issue 4, 2009, Pages 824-831

  Blanco, Miriam Marcela ^a   Dos Santos Jr , Jair Guilherme ^a,b   Perez Mendes, Patrícia ^a   Kohek, Silvia R B ^a   Cavarsan, Clarissa Fantin ^a   Hummel, Michele ^a   Albuquerque, Cristovão ^a   Mello, Luiz E ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

Author keywords

Electroshock model; Nonepileptic animal; Pentylenetetrazole; Pilocarpine

Indexed keywords

PENTETRAZOLE; PHENOBARBITAL; PHENYTOIN; PILOCARPINE; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLONUS; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DRUG SCREENING; ELECTRIC SHOCK; EPILEPSY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE SUSCEPTIBILITY;

ANALYSIS OF VARIANCE; ANIMALS; ANTICONVULSANTS; CONVULSANTS; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; ELECTROENCEPHALOGRAPHY; ELECTROSHOCK; MALE; PENTYLENETETRAZOLE; PILOCARPINE; RATS; RATS, WISTAR; SEIZURES;

EID: 63849285232     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2008.01797.x     Document Type: Article

References (52)

1. Atack JR, Cook SM, Hutson PH, File SE 2000) Kindling induced by pentylenetetrazole in rats is not directly associated with changes in the expression of NMDA or benzodiazepine receptors. Pharmacol Biochem Behav 65 : 743 750.
2. Bazil CW, Pedley TA 1998) Advances in the medical treatment of epilepsy. Annu Rev Med 49 : 135 162.
3. Browning RA, Turner FJ, Simonton RL, Bundman MC 1981) Effect of midbrain and pontine tegmental lesions on the maximal electroshock seizure pattern in rats. Epilepsia 22 : 583 594.
4. Browning RA 1985) Role of the brain-stem reticular formation in tonic-clonic seizures: lesion and pharmacological studies. Fed Proc 44 : 2425 2431.
5. Browning RA, Nelson DK, Mogharreban N, Jobe PC, Laird HE 2nd. 1985) Effect of midbrain and pontine tegmental lesions on audiogenic seizures in genetically epilepsy-prone rats. Epilepsia 26 : 175 183.
6. Browning RA, Nelson DK 1986) Modification of electroshock and pentylenetetrazol seizure patterns in rats after precollicular transections. Exp Neurol 93 : 546 556.
7. Browning RA, Wang C, Lanker ML, Jobe PC 1990) Electroshock- and pentylenetetrazol-induced seizures in genetically epilepsy-prone rats (GEPRs): differences in threshold and pattern. Epilepsy Res 6 : 1 11.
8. Carnevalli LS, Pereira CM, Longo BM, Jaqueta CB, Avedissian M, Mello LE, Castilho BA 2004) Phosphorylation of translation initiation factor eIF2alpha in the brain during pilocarpine-induced status epilepticus in mice. Neurosci Lett 357 : 191 194.
9. De Mello N, Souza-Junior IQ, Carobrez AP 2005) Pilocarpine prevents age-related spatial learning impairments in rats. Behav Brain Res 158 : 263 268.
10. Dichter MA 1997) Basic mechanisms of epilepsy: targets for therapeutic intervention. Epilepsia 38 (Suppl. 9 S2 S6.
11. Eells JB, Clough RW, Browning RA, Jobe PC 1997) Fos in locus coeruleus neurons following audiogenic seizure in the genetically epilepsy-prone rat: comparison to electroshock and pentylenetetrazol seizure models. Neurosci Lett 233 : 21 24.
12. Eells JB, Clough RW, Browning RA, Jobe PC 2004) Comparative fos immunoreactivity in the brain after forebrain, brainstem, or combined seizures induced by electroshock, pentylenetetrazol, focally induced and audiogenic seizures in rats. Neuroscience 123 : 279 292.
13. Kirschstein T, Bauer M, Muller L, Ruschenschmidt C, Reitze M, Becker AJ, Schoch S, Beck H 2007) Loss of metabotropic glutamate receptor-dependent long-term depression via downregulation of mGluR5 after status epilepticus. J Neurosci 27 : 7696 7704.
14. Kitano Y, Komiyama C, Makino M, Takasuna K, Takazawa A, Sakurada S 2005) Anticonvulsant properties of the novel nootropic agent nefiracetam in seizure models of mice and rats. Epilepsia 46 : 811 818.
15. Leite JP, Cavalheiro EA 1995) Effects of conventional antiepileptic drugs in a model of spontaneous recurrent seizures in rats. Epilepsy Res 20 : 93 104.
16. Longo BM, Sanabria ER, Gabriel S, Mello LE 2002) Electrophysiologic abnormalities of the hippocampus in the pilocarpine/cycloheximide model of chronic spontaneous seizures. Epilepsia 43 (Suppl. 5 203 208.
17. Loscher W, Schmidt D 1988) Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res 2 : 145 181.
18. Loscher W, Fassbender CP, Nolting B 1991) The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models. Epilepsy Res 8 : 79 94.
19. Loscher W, Schmidt D 1994) Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation? Epilepsy Res 17 : 95 134.
20. Loscher W 1997) Animal models of intractable epilepsy. Prog Neurobiol 53 : 239 258.
21. Loscher W 1998) New visions in the pharmacology of anticonvulsion. Eur J Pharmacol 342 : 1 13.
22. Loscher W 2002a) Animal models of drug-resistant epilepsy. Novartis Found Symp 243 : 149 159 discussion 159 166.
23. Loscher W 2002b) Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Res 50 : 105 123.
24. Loscher W 2002c) Current status and future directions in the pharmacotherapy of epilepsy. Trends Pharmacol Sci 23 : 113 118.
25. Loscher W, Potschka H 2002) Role of multidrug transporters in pharmacoresistance to antiepileptic drugs. J Pharmacol Exp Ther 301 : 7 14.
26. Loscher W, Schmidt D 2002) New horizons in the development of antiepileptic drugs. Epilepsy Res 50 : 3 16.
27. Loscher W, Schmidt D 2004) New horizons in the development of antiepileptic drugs: the search for new targets. Epilepsy Res 60 : 77 159.
28. Loscher W, Potschka H, Rieck S, Tipold A, Rundfeldt C 2004) Anticonvulsant efficacy of the low-affinity partial benzodiazepine receptor agonist ELB 138 in a dog seizure model and in epileptic dogs with spontaneously recurrent seizures. Epilepsia 45 : 1228 1239.
29. Luszczki JJ, Swiader MJ, Swiader K, Paruszewski R, Turski WA, Czuczwar SJ 2007) Characterization of the anticonvulsant profile of isonicotinic acid benzylamide in various experimental seizure models in mice. Neurosci Lett 421 : 87 90.
30. McNamara JO 1992) The neurobiological basis of epilepsy. Trends Neurosci 15 : 357 359.
31. McNamara JO 1994) Cellular and molecular basis of epilepsy. J Neurosci 14 : 3413 3425.
32. Meldrum BS 1997) Identification and preclinical testing of novel antiepileptic compounds. Epilepsia 38 (Suppl. 9 S7 S15.
33. Meldrum BS 1999) Antiepileptic drugs potentiating GABA. Electroencephalogr Clin Neurophysiol Suppl 50 : 450 457.
34. Meldrum B 2002) Do preclinical seizure models preselect certain adverse effects of antiepileptic drugs. Epilepsy Res 50 : 33 40.
35. Mello LE, Cavalheiro EA, Tan AM, Kupfer WR, Pretorius JK, Babb TL, Finch DM 1993) Circuit mechanisms of seizures in the pilocarpine model of chronic epilepsy: cell loss and mossy fiber sprouting. Epilepsia 34 : 985 995.
36. Mintzer S, Sperling MR 2008) When should a resection sparing mesial structures be considered for temporal lobe epilepsy? Epilepsy Behav 13 : 7 11.
37. Morimoto K, Fahnestock M, Racine RJ 2004) Kindling and status epilepticus models of epilepsy: rewiring the brain. Prog Neurobiol 73 : 1 60.
38. Racine RJ 1972) Modification of seizures activity by electrical stimulation: II Motor seizure. Electroencephalogr Clin Neurophysiol 32.
39. Rogawski MA, Loscher W 2004a) The neurobiology of antiepileptic drugs. Nat Rev Neurosci 5 : 553 564.
40. Rogawski MA, Loscher W 2004b) The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. Nat Med 10 : 685 692.
41. Scarlatelli-Lima AV, Magalhaes LH, Doretto MC, Moraes MF 2003) Assessment of the seizure susceptibility of Wistar Audiogenic rat to electroshock, pentylenetetrazole and pilocarpine. Brain Res 960 : 184 189.
42. Sillanpaa M, Camfield P, Camfield C 1995) Predicting long-term outcome of childhood epilepsy in Nova Scotia, Canada, and Turku, Finland. Validation of a simple scoring system. Arch Neurol 52 : 589 592.
43. Sills GJ, Butler E, Thompson GG, Brodie MJ 2004) Pharmacodynamic interaction studies with topiramate in the pentylenetetrazol and maximal electroshock seizure models. Seizure 13 : 287 295.
44. Sloviter RS 1994a) The functional organization of the hippocampal dentate gyrus and its relevance to the pathogenesis of temporal lobe epilepsy. Ann Neurol 35 : 640 654.
45. Sloviter RS 1994b) On the relationship between neuropathology and pathophysiology in the epileptic hippocampus of humans and experimental animals. Hippocampus 4 : 250 253.
46. Stables JP, Bertram EH, White HS, Coulter DA, Dichter MA, Jacobs MP, Loscher W, Lowenstein DH, Moshe SL, Noebels JL, Davis M 2002) Models for epilepsy and epileptogenesis: report from the NIH workshop, Bethesda, Maryland [see comment]. Epilepsia 43 : 1410 1420.
47. Stables JP, Bertram E, Dudek FE, Holmes G, Mathern G, Pitkanen A, White HS 2003) Therapy discovery for pharmacoresistant epilepsy and for disease-modifying therapeutics: summary of the NIH/NINDS/AES models II workshop. Epilepsia 44 : 1472 1478.
48. Turski WA, Cavalheiro EA, Schwarz M, Czuczwar SJ, Kleinrok Z, Turski L 1983) Limbic seizures produced by pilocarpine in rats: behavioural, electroencephalographic and neuropathological study. Behav Brain Res 9 : 315 335.
49. Turski WA, Cavalheiro EA, Bortolotto ZA, Mello LM, Schwarz M, Turski L 1984) Seizures produced by pilocarpine in mice: a behavioral, electroencephalographic and morphological analysis. Brain Res 321 : 237 253.
50. Velisek L, Kusa R, Kulovana M, Mares P 1990) Excitatory amino acid antagonists and pentylenetetrazol-induced seizures during ontogenesis. I. The effects of 2-amino-7-phosphonoheptanoate. Life Sci 46 : 1349 1357.
51. Velisek L, Roztocilova L, Kusa R, Mares P 1995) Excitatory amino acid antagonists and pentylenetetrazol-induced seizures during ontogenesis: III. The action of kynurenic acid and glutamic acid diethylester. Brain Res Bull 38 : 525 529.
52. Winawer MR, Makarenko N, McCloskey DP, Hintz TM, Nair N, Palmer AA, Scharfman HE 2007) Acute and chronic responses to the convulsant pilocarpine in DBA/2J and A/J mice. Neuroscience 149 : 465 475.